Doyle joins Aro as CMO

Mittie Doyle joined Aro Biotherapeutics Co., a tissue targeted genetic medicines company, as CMO. Doyle was VP, global therapeutic area head, R&D of Immunology at CSL Behring, a CSL Ltd. (ASX:CSL) company. She previously held roles at Shire, Flexion Therapeutics Inc. and Alexion Pharmaceuticals Inc. (NASDAQ:ALXN).

European life science venture firm HealthCap promoted Mårten Steen to co-managing partner from partner. Additionally, the firm hired Kristina Ekberg as partner and general counsel. Ekberg was partner at Vinge, a Swedish law firm. The venture also promoted Carl Kilander to partner from medical associate, Georg Vo Beiske to venture partner from associate, and Alex Valcu to partner from principal...